공황장애의 임상적 특성과 Brain-Derived Neurotrophic Factor 농도와의 관계

키워드

참고문헌 (62)

1. Diagnostic and Statistical Manual of Mental Disorder, "American Psychiatric Association", American Psychiatric Publishing, 430~443 (1994)
2. Hirschfeld RM, "Panic Disorder : Diagnosis, epidemiology, and clinical course", J Clin Psychiatry, 57, pp.3~8 (1996)
3. Sadock BJ, "Kaplan and Sadock’s Synopsis of Psychiatry", pp.599~609 (2003), Williams and Wilkins
4. Rosenbaum JF, "Clinical issues in the long-term treatment of panic disorder", J Clin Psychiatry, 57(Suppl 10), pp.44~48 (1996)
5. Eaton WW, "Panic and panic disorder in the United States", AM J Psychiatry, 151, pp.413~420 (1994)
6. Eaton WW, "Panic Disorder: Clinical, Biological, and Treatment Aspects", pp.50~65 (1995), John Wiley & Sons, Inc
7. Coryell W, "Excess mortality in panic disorder. A comparison with primary unipolar depression", Arch Gen Psychiatry, 39, pp.701~703 (1982)
8. Coryell W, "Mortality among outpatients with anxiety disorders", Am J Psychiatry, 143, pp.508~510 (1986)
9. Rosen JB, "The neurobiology of conditioned and unconditioned fear : a neurobehavioral system analysis of the amygdala", Behav Cogn Neurosci Rev, 3, pp.23~41 (2004)
10. Gorman JM, "Neuroanatomical hypothesis of panic disorder, revised", Am J Psychiatry, 157, pp.493~505 (2000)
11. Nesse RM, "Adrenergic function in patients with panic anxiety", Arch Gen Psychiatry, 41, pp.771~776 (1984)
12. Maron E, "Serotonin function in panic disorder: important, but why?", Neuropsychopharmacol, 31, pp.1~11 (2006)
13. Kent JM, "Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety", Biol Psychiatry, 44, pp.812~824 (1998)
14. iomazenil measurement of the benzodiazepine receptor in panic disorder, "Biol Psychiatry", 2000, 96~106
15. Malizia AL, "Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder : preliminary results from a quantitative PET study", Arch Gen Psychiatry, 55, pp.715~720 (1998)
16. Abelson JL, "HPA axis activity in patients with panic disorder : review and synthesis of four studies", Depress Anxiety, 24, pp.66~76 (2007)
17. Lewin GR, "Physiology of the neurotrophins", Annu Rev Neurosci, 19, pp.289~317 (1996)
18. Lindsay RM, "Neurotrophic factors : from molecule to man", Trends Neurosci, 17, pp.182~190 (1994)
19. Numata S, "Brain-derived neutrotrophic factor(BDNF)Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms", Neurosci Lett, 401, pp.1~5 (2006)
20. Lin PY, "State-dependent decrease in levels of brain-derived neurotrophic factor in bipolar disorder : a meta-analytic study", Neurosci Lett, 466, pp.139~143 (2009)
21. Shim SH, "Increased levels of plasma brain-derived neurotrophic factor(BDNF)in children with attention deficit-hyperactivity disorder(ADHD)", Prog Neuropsychopharmacol Biol Psychiatry, 32, pp.1824~1828 (2008)
22. Fujimura H, "Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation", Thromb Haemost, 87, pp.728~734 (2002)
23. Rosenfeld RD, "Purification and identification of brain-derived neurotrophic factor from human serum", Protein Expr Purif, 6, pp.465~471 (1995)
24. Pan W, "Transport of brain-derived neurotrophic factor across the blood-brain barrier", Neuropharmacol, 37, pp.1553~1561 (1998)
25. Poduslo JF, "Permeability at the blood-brain and blood nerve barriers of the neurotrophic factors : NGF, CNTF, NT-3, BDNF", Brain Res Mol Brain Res, 36, pp.280~286 (1996)
26. Kobayashi K, "Serum brain-derived neurotrophic factor(BDNF)levels in patients with panic disorder : As a biological predictor of response to group cognitive behavioral therapy", Prog neuro-psychopharmacol Biol Psychiatry, 29, pp.658~663 (2005)
27. Lam P, "Association study of a Brain-Derived Neurotrophic Factor(Val 66Met)Genetic polymorphism and Panic disorder", Neuropsychobiol, 49, pp.178~181 (2004)
28. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-P), version 2, "First MB", New York State Psychiatric Institute, Biometrics Research, ~ (1995)
29. 이중서, "한국판 Hamilton 우울증 평가 척도의 신뢰도, 타당도 연구", 신경정신의학, 44(4), pp.456~465 (2005), 대한신경정신의학회
30. Structured Clinical Interview for DSM-IV Axis I Disorders-Non-Patient Edition (SCID-I, "NP), version 2.0", First MB, 1996
31. Pollack MH, "WCA Recommendations for the Long-Term Treatment of Panic Disorder", CNS Spectrums, 8, pp.S17~S30 (2003)
32. Fiammetta C, "The psychological development of panic disorder: implications for neurobiology and treatment", Rev Bras Psiquiatr, 34, pp.S09~S31 (2012)
33. Holmes TH, "The social readjustment rating scale", Journal of Psychosomatic Research, 11(2), pp.213~218 (1967)
34. Hong KE, "Construction of Korean ‘social readjustment rating scale’-A methodological study-", Journal of Korean Neuropsychiatric Association, 21, pp.123~136 (1982)
35. Beck AT, "Manual for the Beck Depression Inventory-II" (1996), Psychological Corporation
36. Spielberger C, "Manual for the State-Trait Anxiety Inventory" (1983), Consulting Psychologists Press
37. Kim JB, "Development of the Korean Version of the Panic Disorder Severity Scale", Korean J Psychopathol, 10, pp.140~151 (2001)
38. Hamilton M, "The assessment of anxiety states by rating", Br J Med Psychology, 32, pp.50~55 (1959)
39. Radka SF, "Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay", Brain Res, 709, pp.122~301 (1996)
40. Gold SM, "Basal serum levels and reactivity of nerve growth factor and brain-derived neurotrophic factor to standardized acute exercise in multiple sclerosis and controls", J Neuroimmunol, 138, pp.99~105 (2003)
41. Angelucci F, "Transcranial magnetic stimulation and BDNF plasma levels in amyotrophic lateral sclerosis", Neuroreport, 15, pp.717~720 (2004)
42. Karege F, "Low brain-derived neurotrophic factor(BDNF)levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity", Biol Psychiatry, 57, pp.1068~1072 (2005)
43. Laghrissi-Thode F, "Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease", Biol Psychiatry, 42, pp.290~295 (1997)
44. Musselman DL, "Exaggerated platelet reactivity in major depression", Am J Psychiatry, 153, pp.1313~1317 (1996)
45. Lee BH, "Reduced platelet BDNF level in patients with major depression", Prog Neuropsychopharmacol Biol Psychiatry, 33, pp.849~853 (2009)
46. Lee BH, "BDNF mRNA in peripheral blood mononuclear cells of depressive patients with or without attempted suicide", Poster presentation in The Korean Neuropsychiatric Association The 50th Annual Meeting (2007)
47. Mattson MP, "BDNF and 5-HT : a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders", Trends Neurosci, 27, pp.589~594 (2004)
48. Brindle PK, "The CREB family of transcription activators", Curr Opin Genet Dev, 2, pp.199~204 (1992)
49. Nibuya M, "Chronic antidepressant administration increases the expression of cAMP response element binding protein(CREB)in rat hippocampus", J Neurosci, 16, pp.2365~2372 (1996)
50. Asberg M, "Neurotransmitters and suicidal behavior. The evidence from cerebrospinal fluid studies", Ann N Y Acad Sci, 836, pp.158~181 (1997)
51. Kasper S, "Panic disorder : the place of benzodiazepines and selective serotonin reuptake inhibitors", Eur Neuropsychopharmacol, 11, pp.307~321 (2001)
52. Van Der Kolk BA, "The psychobiology and psychopharmacology of PTSD", Hum Psychopharmacol, 16, pp.S49~S64 (2001)
53. Baldwin DS, "Evidence-based pharmacological treatment of generalized anxiety disorder", Int J Neuropsychopharmacol, 14, pp.697~710 (2011)
54. Spina MB, "Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity : involvement of the glutathione system", J Neurochem, 59, pp.99~106 (1992)
55. Smith MA, "Stress and glucocorticoids affect the expression of brainderived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus", J Neurosci, 15, pp.1768~1777 (1995)
56. Marmigere F, "Rapid induction of BDNF expression in the hippocampus during immobilization stress challenge in adult rats", Hippocampus, 13, pp.646~655 (2003)
57. Molteni R, "Acute stress responsiveness of the neurotrophin BDNF in the rat hippocampus is modulated by chronic treatment with the antidepressant duloxetine", Neuropsychopharmacol, 34, pp.1523~1532 (2009)
58. 김용구, "우울증 환자의 혈액에서 측정되는 BDNF 농도 변화와 그 의미", 신경정신의학, 48(4), pp.203~206 (2009), 대한신경정신의학회
59. Murakamia S, "Chronic stress, as well as acute stress, reduces BDNF mRNA expression in the rat hippocampus but less robustly", Neuroscience Research, 53, pp.129~139 (2005)
60. Ziegenhorn AA, "Serum neurotrophins : a study on the time course and influencing factors in a large old age sample", Neurobiol Aging, 28, pp.1436~1445 (2007)
61. Trajkovska V, "Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data", Brain Res Bull, 73, pp.143~ (2007)
62. Lommatzsch M, "The impact of age, weight and gender on BDNF levels in human platelets and plasma", Neurobiol. Aging, 26, pp.115~123 (2005)

관련 논문AI추천